This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effectiveness and safety of once-daily LABA/ICS in a combined inhaler versus once/twice-daily LABA for the treatment of COPD.
CITATION STYLE
Patricia Hidalgo, M., Celis, C. A., Rojas-Reyes, M. X., & Dennis, R. J. (2016, February 29). Once-daily LABA/ICS combined inhalers versus inhaled long-acting beta2-agonists for people with chronic obstructive pulmonary disease (COPD). Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd. https://doi.org/10.1002/14651858.CD012100
Mendeley helps you to discover research relevant for your work.